Advertisment

FDA Warns of Potential Safety Issue with Philips Respironics' DreamStation 2 CPAP Machines

author-image
BNN Correspondents
New Update
FDA Warns of Potential Safety Issue with Philips Respironics' DreamStation 2 CPAP Machines

In an alarming development, the U.S. Food and Drug Administration (FDA) has issued a safety communication regarding Philips Respironics' DreamStation 2 Continuous Positive Airway Pressure (CPAP) machines. These devices are typically used for treating various forms of sleep apnea, a sleep disorder characterized by breathing interruptions during sleep. The FDA's warning focuses on potential thermal issues that could pose a risk to patients using these machines.

Advertisment

Emerging Safety Issue

The FDA's communication is in response to multiple reports involving thermal issues with the machine, some even citing patient injuries. The agency is advising patients and healthcare providers to vigilantly monitor these machines for signs of overheating. The decision to issue this communication is part of the FDA's commitment to safeguard and promote public health.

Patient Safety at Risk

Advertisment

Reports of fire, smoke, burns, and other signs of overheating while using Philips DreamStation 2 CPAP machines have been received by the FDA. The medical device safety agency said it recently experienced an influx of such medical device reports (MDRs), signifying a serious safety concern for patients. This warning follows previous safety alerts for Philips respiratory devices, with more than 5 million of them having been recalled due to dangerous degradation of sound abatement foam.

Recommended Course of Action

For patients using these CPAP machines, the FDA recommends inspecting them for unusual smells or changes in appearance before and after each use. The agency has received over 270 reports about Philips Respironics' DreamStation 2 CPAP machines overheating, which could potentially lead to injury. This recommendation aims to ensure the patients' safety and prevent any potential harm.

The FDA's efforts to alert patients and healthcare providers about this issue are ongoing. The safety communication serves to inform the public about the potential risks associated with the use of Philips' DreamStation 2 CPAP machines and to ensure that they are vigilant in observing their CPAP machines for any signs of malfunction or safety concerns.

Advertisment
Advertisment